AerovectRx Overview
"AerovectRx Corporation is an aerosol therapeutic company providing proprietary dosage-controlled solutions to the $20 billion inhaled drug delivery market. Our FDA-cleared AeroCellâ„¢ disposable drug cartridge is unique to the industry and is designed to improve patient compliance and eliminate cross contamination. Our device and disposable product platform is uniquely suited to deliver a wide...More»
"AerovectRx Corporation is an aerosol therapeutic company providing proprietary dosage-controlled solutions to the $20 billion inhaled drug delivery market. Our FDA-cleared AeroCellâ„¢ disposable drug cartridge is unique to the industry and is designed to improve patient compliance and eliminate cross contamination. Our device and disposable product platform is uniquely suited to deliver a wide variety of vaccine and therapies varying from multiple-use mass immunizations, specialty pharmaceutical and personal home care use. The technology was developed by the U.S. CDC and licensed exclusively to AerovectRx."
(Source: AerovectRx )«Less
Key People
Management
- Edward Cannon, Chief Executive Officer
- P. Kathleen Lovell, Chairman of the Board of Directors
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Jonathan Mow, Director
- David Johnson, Director
- Edward Cannon, Chief Executive Officer
- P. Kathleen Lovell, Chairman of the Board of Directors
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Glen Bradley, Director
- Thomas Callaway, Director
- Jonathan Mow, Director
- Thomas Callaway, Director
- P. Kathleen Lovell, Chairman of the Board of Directors
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Glen Bradley, Director
- Thomas Callaway, Director
- Jonathan Mow, Director
- Edward Cannon, Chief Executive Officer
- P. Kathleen Lovell, Chairman of the Board of Directors
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Glen Bradley, Director
- Thomas Callaway, Director
- Edward Cannon, Chief Executive Officer
- Jonathan Mow, Director
- P. Kathleen Lovell, Chairman of the Board of Directors
- Edward Cannon, Chief Executive Officer
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- P. Kathleen Lovell, Chairman of the Board of Directors
- Glen Bradley, Director
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Thomas Callaway, Director
- Glen Bradley, Director
- Jonathan Mow, Director
- Thomas Callaway, Director
- Jonathan Mow, Director
- Edward Cannon, Chief Executive Officer
- P. Kathleen Lovell, Chairman of the Board of Directors
- Matthew H.J. Kim, Founder, Vice President Licensing and Business Development
- Glen Bradley, Director
- Thomas Callaway, Director
- John P. Richard, Director
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 04/2008 | Seed | 1.2M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
No related companies were found.
Page Information
09/11/2008 02:40AM by TradeVibes
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Senior Pharmaceutical Executive Joins AerovectRx Board
Apr 10, 2008 - 0 comments
Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.

loading...
